GILD Competitors
Gilead Sciences, Inc.
$167.95
-$1.78(-1.05%)
68
Overall
80
Value
66
Tech
60
Quality
Market Cap
$208.31B
Volume
4.23M
52W Range
$116.88 - $176.58
Target Price
$173.55
GILD competitors: AMGN, VRTX, ABBV, BIIB, ILMN. Gilead Sciences, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
GILD Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc. | $468.10 | $253.21B | $23.52 | 2.12% | 66 |
| VRTX Vertex Pharmaceuticals Incorporated | $544.14 | $138.69B | $18.12 | - | 62 |
| ABBV AbbVie Inc. | $295.31 | $521.41B | $13.98 | 2.34% | 58 |
| BIIB Biogen Inc. | $251.30 | $37.46B | $12.53 | - | 64 |
| ILMN Illumina, Inc. | $210.50 | $32.20B | $5.48 | - | 45 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GILD | $167.95 | -1.0% | 4.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |